Wyeth officials say their hormone replacement therapy Prempro is not the cause of one Ohio woman's breast cancer. But two jury decisions prove otherwise.

The first jury, in October, awarded Jennie Nelson and her husband $1.5 million in compensatory damages, validating Nelson's claim that her breast cancer -- resulting in a double mastectomy, chemotherapy, and radiation -- was caused by the Prempro she took for six years. When this verdict was thrown out due to a mistrial, a retrial began.

The retrial concluded yesterday -- with a Philadelphia jury awarding the Nelsons this time with $3 million.

"Both times this case has been heard on terms established by Wyeth and still the juries have clearly found that Prempro causes breast cancer," says Nelson's attorney Tobias Millrood, adding that Wyeth puts sales ahead of patient safety.

Wyeth respectfully disagrees and argues that it acted responsibly in the promotion of its hormone replacement products and in disclosing with doctors and patients all therapy-associated health risks.

Millions of women have used Wyeth's hormone replacement therapies to control the effects of menopause, and the company, sanctioned in January to pay $1 million to an Arkansas breast cancer survivor, now faces more than 5,000 lawsuits of this same nature.

Despite a large-scale study revealing drugs like Prempro increase the risk of breast cancer if used for five years or more, the drug still remains on the market. And Wyeth is so sure their drug is not at fault for causing Nelson's breast cancer that they plan to appeal yesterday's verdict.

An Arkansas woman claiming the hormone replacement drug Prempro caused her breast cancer just won her legal battle against Wyeth, the maker of the drug.

Mary Daniel was awarded $1 million in compensatory damages thanks to a Philadelphia jury decision stating Wyeth acted with malice or reckless disregard for selling Prempro -- the drug Daniels took for 16 months to relieve hot flashes. The next step for Daniels, whose husband will receive $500,000, is a hearing to consider punitive damages.

Wyeth's lawyer argues that Prempro -- a combination of estrogen and progestin -- is still prescribed to women and suggests Daniel's breast cancer was caused by other risk factors, such as family history of the disease.

Former contestant Elliott Yamin was the third runner-up on the most recent season of American Idol. But he comes in first place for 19-year-old fan Amanda Jones whose dream after her diagnosis with leukemia was was to meet Yamin. Her dream came true this weekend when she got the chance to meet Yamin backstage at the "American Idols Live" tour in Richmond, Virgina -- Yamin's hometown.

Jones, from Jonesboro, Arkansas, is such a fan of Yamin's that in May she camped out at Graceland in Memphis just to catch a glimpse of him when the top Idol contestants were visiting the former home of Elvis. Now that she knows Yamin a bit better, Jones feels a real connection with him. "He's my hero. He went through so much in his childhood, struggled through so much, and in the end, he came out on top. That's what I pray and hope I can do," she said.

Yamin, 28, is no stranger to health concerns. He suffers from Type 1 diabetes and is also deaf in one ear -- as a result of repeated childhood ear infections and an ear-drum replacement surgery at the age of 13 that just didn't work out right. Still, he overcame his obstacles and has made a name for himself as a talented singer. Jones wants to overcome her obstacles too. For now, though, she is just happy Yamin helped her forget for a moment that she is a kid with leukemia.